Acceptability of Naloxone Dispensing Among Pharmacists (original) (raw)
Attitudes and perceptions of naloxone dispensing among a sample of Massachusetts community pharmacy technicians
Traci Green
Journal of the American Pharmacists Association
View PDFchevron_right
Assessing pharmacists’ readiness to dispense naloxone and counsel on responding to opioid overdoses
Carly Levy
Journal of the American Pharmacists Association, 2019
View PDFchevron_right
Rural and small metro area naloxone-dispensing pharmacists' attitudes, experiences, and support for a frontline public health pharmacy role to increase naloxone uptake in New York State, 2019
Crystal Fuller Lewis
Journal of Substance Abuse Treatment, 2021
View PDFchevron_right
Pharmacists' role in opioid overdose: Kentucky pharmacists' willingness to participate in naloxone dispensing
Suzanne Troske
Journal of the American Pharmacists Association : JAPhA
View PDFchevron_right
Naloxone Availability in Community Pharmacies, 2019
Jennifer Nguyen
2021
View PDFchevron_right
Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United States
Zhengyan Huang
JAMA Network Open, 2019
View PDFchevron_right
Orienting patients to greater opioid safety: models of community pharmacy-based naloxone
Traci Green
Harm Reduction Journal, 2015
View PDFchevron_right
PHArmacists’ perspective oN the Take hOme naloxone prograM (The PHANTOM Study)
duane bates
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, 2017
View PDFchevron_right
The state of naloxone: Access amid a public health crisis
Jeffrey Fudin
Medicine Access @ Point of Care
View PDFchevron_right
Physicians’ Knowledge of and Willingness to Prescribe Naloxone to Reverse Accidental Opiate Overdose: Challenges and Opportunities
Leo Beletsky
Journal of Urban Health, 2007
View PDFchevron_right
Primary Care Patient Experience with Naloxone Prescription
Phillip Coffin
Annals of family medicine, 2016
View PDFchevron_right
Awareness of state legislation on naloxone accessibility associated with willingness to prescribe naloxone
Olihe Okoro
Substance Abuse, 2017
View PDFchevron_right
Preliminary Evidence of Health Care Provider Support for Naloxone Prescription as Overdose Fatality Prevention Strategy in New York City
David Vlahov, Phillip Coffin
Journal of Urban Health: Bulletin of the New York Academy of Medicine, 2003
View PDFchevron_right
Naloxone availability and dispensing in Indiana pharmacies 2 years after the implementation of a statewide standing order
Beth E Meyerson
Journal of the American Pharmacists Association, 2020
View PDFchevron_right
If We Build It, Will They Come? Perspectives on Pharmacy-Based Naloxone Among Family and Friends of People who use Opioids: A Mixed Methods Study
Susannah Slocum
2021
View PDFchevron_right
Barriers to and recommendations for take-home naloxone distribution: perspectives from opioid treatment programs in New Mexico
Joanna Katzman
Harm Reduction Journal
View PDFchevron_right
Pharmacists’ experiences with a statewide naloxone standing order program in Massachusetts: a mixed methods study
Susannah Slocum
Journal of the American Pharmacists Association, 2021
View PDFchevron_right
Facilitators and Barriers to Naloxone Kit Use Among Opioid-Dependent Patients Seeking Treatment at Medication Assisted Therapy Clinics in North Carolina, USA ABSTRACT Facilitators and Barriers to Naloxone Kit Use Among Opioid-Dependent Patients Seeking Treatment at Medication Assisted Therapy Cli...
Prasana Khatiwoda
2016
View PDFchevron_right
Pharmacy-based statewide naloxone distribution: A novel "top-down, bottom-up" approach
Claire Logan
Journal of the American Pharmacists Association : JAPhA
View PDFchevron_right
Investigating Community Pharmacy Take Home Naloxone Dispensing during COVID-19: The Impact of One Public Health Crisis on Another
Ashley Polanco Cid
Pharmacy, 2021
View PDFchevron_right
How prepared are pharmacists to provide over-the-counter naloxone? The role of previous education and new training opportunities
Meng-Wong Taing
Research in Social and Administrative Pharmacy
View PDFchevron_right
Factors Associated With Participation in an Emergency Department-Based Take-Home Naloxone Program for At-Risk Opioid Users
Amanda Giesler
Annals of emergency medicine, 2016
View PDFchevron_right
Attitudes of Emergency Medical Service Providers Towards Naloxone Distribution Programs
Carl Latkin
Journal of Urban Health: Bulletin of the New York Academy of Medicine, 2005
View PDFchevron_right
Attitudes Toward Naloxone Prescribing in Clinical Settings: A Qualitative Study of Patients Prescribed High Dose Opioids for Chronic Non-Cancer Pain
steve koester
Journal of general internal medicine, 2017
View PDFchevron_right
Naloxone availability in independent community pharmacies in Georgia, 2019
Jennifer Nguyen
2021
View PDFchevron_right
Evaluation of a Naloxone Distribution and Administration Program in New York City
Susan Sherman
Substance Use & Misuse, 2008
View PDFchevron_right
Socio-ecological and pharmacy-level factors associated with naloxone stocking at standing-order naloxone pharmacies in New York City
Dr. Dawn A. Goddard-Eckrich
Drug and Alcohol Dependence, 2021
View PDFchevron_right
Physician and Pharmacist: Attitudes, Facilitators, and Barriers to Prescribing Naloxone for Home Rescue
Carla Marienfeld
The American Journal on Addictions, 2019
View PDFchevron_right
Naloxone Prescriptions Among Commercially Insured Individuals at High Risk of Opioid Overdose
Sarah Follman
JAMA Network Open
View PDFchevron_right
Stakeholders’ Perceptions of Factors Influencing the Use of Take-Home-Naloxone
Betty Chaar
Pharmacy
View PDFchevron_right
How do contextual factors influence naloxone distribution from syringe service programs in the USA: a cross-sectional study
Savannah O'Neill
Harm Reduction Journal, 2023
View PDFchevron_right